INTS8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.629600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.330000E-01
Normal-vs-Stage2
9.735000E-01
Normal-vs-Stage3
2.164400E-01
Normal-vs-Stage4
7.291200E-01
Stage1-vs-Stage2
7.455000E-01
Stage1-vs-Stage3
1.112370E-01
Stage1-vs-Stage4
8.359400E-01
Stage2-vs-Stage3
8.244400E-02
Stage2-vs-Stage4
5.828000E-01
Stage3-vs-Stage4
1.190450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.578000E-01
Normal-vs-AfricanAmerican
6.250800E-01
Normal-vs-Asian
8.886400E-01
Caucasian-vs-AfricanAmerican
4.979600E-01
Caucasian-vs-Asian
6.984400E-01
AfricanAmerican-vs-Asian
4.002400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.421000E-01
Normal-vs-Female
8.530200E-01
Male-vs-Female
3.220200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.367800E-01
Normal-vs-Age(41-60Yrs)
7.592000E-01
Normal-vs-Age(61-80Yrs)
8.419000E-01
Normal-vs-Age(81-100Yrs)
9.596600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.414800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.053200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.472800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.290100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.994200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.795600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.500800E-01
Normal-vs-Daily Drinker
9.187000E-01
Normal-vs-Weekly Drinker
5.760000E-01
Normal-vs-Occasional Drinker
8.781800E-01
Normal-vs-Social Drinker
8.488400E-01
Non Drinker-vs-Daily Drinker
9.369400E-01
Non Drinker-vs-Weekly Drinker
6.135200E-01
Non Drinker-vs-Occasional Drinker
4.795800E-01
Non Drinker-vs-Social Drinker
4.515000E-01
Daily Drinker-vs-Weekly Drinker
6.191200E-01
Daily Drinker-vs-Occasional Drinker
6.365000E-01
Daily Drinker-vs-Social Drinker
6.142400E-01
Weekly Drinker-vs-Occasional Drinker
2.782200E-01
Weekly Drinker-vs-Social Drinker
2.490600E-01
Occasional Drinker-vs-Social Drinker
9.482000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.579200E-01
Normal-vs-Grade 2
5.732000E-01
Normal-vs-Grade 3
1.147040E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.801800E-02
Grade 1-vs-Grade 3
2.489800E-02
Grade 1-vs-Grade 4
3.579200E-01
Grade 2-vs-Grade 3
2.399400E-01
Grade 2-vs-Grade 4
5.732000E-01
Grade 3-vs-Grade 4
1.147040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.734600E-01
Normal-vs-NonDiabetic
8.751000E-01
Diabetic-vs-NonDiabetic
6.160200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.939200E-01
Normal-vs-NoPancreatitis
8.396200E-01
Pancreatitis-vs-NoPancreatitis
3.530200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.450800E-01
Normal-vs-N1
9.925800E-01
N0-vs-N1
7.769800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.831000E-01
Normal-vs-TP53-NonMutant
8.707400E-01
TP53-Mutant-vs-TP53-NonMutant
2.238300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
